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Summary
Background.  —  Few  studies  have  compared  conventional  testing  with  prolonged  monitoring
using an  implantable  loop  recorder  (ILR)  following  the  ﬁrst  syncope  episode  in  patients  with
bundle branch  block  (BBB)  and  negative  workup.
Objectives.  —  To  compare  two  syncope  evaluation  strategies—primary  use  of  an  ILR  (Group  1)
versus conventional  testing  (Group  2)—and  to  estimate  the  prevalence  of  signiﬁcant  arrhythmias
in the  ILR  patient  subset.
Methods.  —  From  January  2005  to  December  2010,  78  patients  admitted  after  one  syncope
episode were  randomized  to  ILR  (n  =  41)  or  conventional  follow-up  (n  =  37).  Mean  follow-up  was
27 ±  12  months.
Results.  —  Mean  age  was  76  ±  8  years  and  30  patients  were  women  (38.5%);  18  presented  car-
diomyopathy  (23%)  and  12  had  a  history  of  atrial  ﬁbrillation  (15.4%).  Mean  left  ventricular
ejection  fraction  was  56.5  ±  11%  and  mean  His-to-ventricle  interval  was  55  ±  6  ms  based  on
negative electrophysiological  study  (EPS).  Electrocardiogram  abnormalities  involved:  34  left
bundle branch  blocks  (BBBs);  11  right  BBBs;  and  33  bifascicular  blocks.  Overall,  21  patients
(27%) developed  signiﬁcant  arrhythmic  events:  ventricular  tachycardia  (n  =  1;  1.3%);  sudden
death (n  =  2;  2.6%);  third-degree  atrioventricular  (AV)  block  (n  =  14;  18%);  sick  sinus  syndrome
(n =  4;  5.1%).  In  19  (24.4%)  patients,  relevant  arrhythmias  were  detected,  with  a  signiﬁcant
difference  between  the  ILR  group  (n  =  15/41;  36.6%)  and  the  conventional  follow-up  group
(n =  4/37;  10.8%)  (P  =  0.02).  Eighteen  patients  were  implanted  with  pacemakers;  one  received
an implantable  deﬁbrillator.  No  predictors  of  AV  block  were  identiﬁed  in  the  ILR  group.
Conclusions.  —  In  this  randomized  prospective  study,  the  ILR  strategy  proved  largely  superior  to
conventional  follow-up  in  detecting  recurrent  events,  with  a  potential  impact  on  therapeutic
management.  This  observation  highlights  the  usefulness  of  early  monitoring  in  patients  with
BBB and  negative  EPS  even  after  the  ﬁrst  syncope  episode  but  an  empiric  pacemaker  strategy
remains  to  be  validated  in  this  selected  population.
© 2013  Published  by  Elsevier  Masson  SAS.
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Résumé
Contexte.  —  Les  données  publiées  sur  le  mécanisme  des  syncopes  isolées  chez  les  patients  avec
bloc de  branche  complet  (BBC)  et  bilan  électrophysiologique  négatif  sont  peu  nombreuses.
Objectifs.  —  De  comparer  pour  les  patients  avec  première  syncope  et  BBC  une  stratégie  avec
mise en  place  d’un  moniteur  ECG  implantable  (MEI)  (Group  I)  versus  un  suivi  conventionnel
clinique et  holter  (Group  II).
Méthodes.  — De  janvier  2005  à  décembre  2010,  78  patients  (76  ±  8  ans)  ont  été  randomisés,
41 patients  dans  le  groupe  MEI  et  37  patients  dans  le  groupe  suivi  conventionnel.  Le  suivi  moyen
était de  27  ±  12  mois.
Résultats.  — Les  troubles  de  conduction  étaient  les  suivants  :  34  BBC  gauche,  11  BBC  droit  et
33 blocs  bifasciculaires.  Dans  l’ensemble  de  la  population,  21  patients  (27  %)  ont  développé  un
évènement  rythmique  :  une  TV  dans  un  cas  (1,3  %),  une  mort  subite  dans  deux  cas  (2,6  %),  un
BAV du  3e degré  chez  14  patients  (18  %)  et  une  dysfonction  sinusale  dans  quatre  cas  (5,1  %).  Pour
19 patients  (24,4  %),  la  détection  d’un  évènement  rythmique  a  été  possible,  avec  une  différence
signiﬁcative  entre  les  deux  groupes  de  suivi  :  MEI  (n  =  15/41  ;  36,6  %)  versus  suivi  conventionnel
(n =  4/37  ;  10,8  %)  (p  =  0,02).  Par  conséquent,  18  patients  ont  bénéﬁcié  de  l’implantation  d’un
pacemaker  et  un  patient  de  la  mise  en  place  d’un  déﬁbrillateur.
Conclusions.  —  Cette  étude  prospective  randomisée  multicentrique  chez  des  patients  avec  un
épisode de  syncope  associé  à  un  BBC  et  une  exploration  électrophysiologique  négative  montre
que la  stratégie  du  MEI  est  très  largement  supérieure  au  suivi  traditionnel.  Dans  le  groupe  avec
MEI, la  prévalence  des  évènements  rythmiques  était  de  36,6  %  à  2,5  ans  (14,6  %  par  an)  versus
 grou
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Background
Cardiac  syncope  doubles  the  risk  of  all-cause  death,  while
increasing  the  risk  of  fatal  and  non-fatal  cardiovascular
events  [1].  Soteriades  et  al.  demonstrated  that  subjects  with
syncope  of  unknown  aetiology  comprise  a  heterogeneous
m
t
lpe  de  suivi  conventionnel.
n  SAS.
atient  group  with  an  increased  risk  of  death  [1].  The
urrent  approach  to  investigating  patients  with  unex-
lained  syncope  involves  short-term  electrocardiographic
onitoring  or  tests  such  as  head-up  tilt  testing  and  elec-
rophysiological  study  (EPS)  [2—6]. Recent  advances  in
ong-term  monitoring  with  an  implantable  loop  recorder
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induction  of  rapid  supraventricular  arrhythmia  associated48  
ILR)  have  enabled  clinicians  to  obtain  a  correlation  between
ymptoms  and  rhythm  in  the  majority  of  patients  [7—14].
espite  the  number  of  published  reports  on  ILRs,  only  a  few
andomized  studies  are  available,  with  their  major  limita-
ions  being  small  sample  size  and  short-term  follow-up  [11].
urthermore,  most  published  trials  included  patients  with
ecurrent  syncope,  with  three  to  seven  syncope  episodes
8—14].
In  patients  with  both  syncope  and  bundle  branch  block
BBB),  syncope  is  suspected  to  be  attributed  to  atrioven-
ricular  (AV)  block,  with  EPS  being  able  to  predict  the
evelopment  of  AV  block  in  87%  of  patients  [15]. In  patients
ith  BBB  and  negative  EPS,  the  risk  of  developing  a  sta-
le  AV  block  was  shown  to  be  close  to  20%  after  4  years,
ith  the  risk  of  syncope  recurrence  being  close  to  40%  at
 years  [16—18]. Given  this  clinical  setting,  Brignole  et  al.
ound  that  syncope  recurrences  were  mainly  accounted  for
y  paroxysmal  AV  block,  with  the  risk  estimated  at  34%  at
5  months  (27%  incidence/year),  suggesting  that  some  EPS
esults  were,  in  fact,  false  negatives  [16]. Accordingly,  an
LR  was  shown  to  be  able  to  establish  a  symptom-rhythm  cor-
elation  in  most  patients  with  recurrent  syncope  [11,16,19].
o  date,  there  are  little  data  available  regarding  patients
ith  a  ﬁrst  syncope  episode,  BBB  and  negative  workup,
ncluding  EPS.  Moreover,  in  this  subset  of  patients  with  initial
egative  EPS  results,  no  randomized  studies  have  compared
 conventional  monitoring  strategy  (clinical,  electrocardio-
ram  and  standard  Holter  monitoring)  with  ILR  following  a
rst  syncope  episode,  despite  the  European  Society  of  Car-
iology  guidelines  of  2009  [19]. In  these  guidelines,  patients
ith  left  BBB  are  considered  at  high  risk  and  syncope  in  these
atients  should  lead  to  an  ILR  (class  I,  level  B)  [19]. The  rec-
mmendation  for  patients  with  syncope  and  left  BBB  could
ead  to  pacemaker  implantation  but  the  level  of  proof  is  con-
idered  as  class  IIa,  level  C  [19]. A  recent  paper  underlined
he  role  of  ILRs  in  a  subset  of  patients  despite  negative  EPS
ut  patients  could  have  had  more  than  one  syncope  episode
20].
The  aim  of  this  multicentre  prospective  study  was  to  com-
are  two  syncope  evaluation  strategies—namely,  the  use  of
n  ILR  (Group  1)  versus  conventional  follow-up  (Group  2)—in
 population  of  patients  with  BBB  and  negative  EPS  following
 ﬁrst  syncope  episode,  in  addition  to  assessing  the  preva-
ence  of  signiﬁcant  arrhythmic  events  in  the  ILR  patient
ubset.
ethods
tudy population
he  study  protocol  was  approved  by  the  Institutional
esearch  Board  of  the  Saint-Étienne  Hospital  and  the  Ethics
ommittee  in  October  2004.  The  study  was  supported  by
he  Ministère  Franc¸ais de  la  Santé  (Projet  Hospitalier  de
echerche  Clinique,  2003)  and  Saint-Étienne  University  Hos-
ital.nclusion criteria
atients  admitted  after  one  syncope  episode  were  invited  to
articipate  in  this  prospective  randomized  trial  comparing
w
h
n
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wo  diagnostic  approaches  to  syncope.  Consecutive  patients
ere  included  in  the  trial  if  they  met  the  following  inclusion
riteria:  single  syncopal  episode  associated  with  any  type
f  BBB  with  QRS  greater  or  equal  to  120  ms;  no  evidence
f  second-  or  third-degree  AV  block;  and  negative  workup
ncluding  EPS.  Prior  to  enrolment,  patients  underwent  clin-
cal  assessment,  involving  postural  blood  pressure  testing,
aseline  ambulatory  monitoring  or  inpatient  telemetry  for
t  least  24  hours  and  transthoracic  echocardiogram.  Base-
ine  Holter  assessment  was  considered  negative  if  patients
id  not  experience  syncope  or  presyncope  reminiscent  of
heir  referral  symptoms  during  the  recording  and  if  there
as  no  evidence  of  the  following:  asymptomatic  second-
r  third-degree  AV  block;  pauses  of  at  least  3  seconds;  sus-
ained  supraventricular  tachycardia  or  greater  or  equal  to
0  beats  of  wide  QRS  complex  tachycardia  likely  to  repre-
ent  ventricular  tachycardia.  Before  enrolment,  additional
eurological  or  cardiovascular  testing  was  performed  by  the
eferring  physician,  although  this  was  not  mandatory  accord-
ng  to  the  protocol.  Patients  were  excluded  if  one  of  the
ollowing  conditions  was  found:  left  ventricular  ejection
raction  (LVEF)  less  or  equal  to  35%;  unlikelihood  of  surviv-
ng  1  year;  or  inability  to  attend  follow-up  or  give  informed
onsent.  Patients  with  LVEF  less  than  60%  were  consid-
red  as  having  cardiomyopathy  and  thus  were  included.  The
ifference  between  ischaemic  cardiomyopathy  and  dilated
ardiomyopathy  was  based  on  the  coronary  angiography
alues.  Patients  with  a  typical  presentation  of  neurally
ediated  syncope  at  baseline  were  diagnosed  as  such  and
xcluded  from  participating  in  the  study.  The  clinical  symp-
oms  of  neurally  mediated  syncope  were  induced  by  upright
osture,  with  a  prodromal  phase,  including  the  feeling  of
armth  and  excessive  sweating,  followed  by  postepisode
omplaints  of  fatigue.  The  EPS  included  the  measurement
f  the  sinus  node  recovery  time  in  addition  to  the  mea-
urement  of  the  His  to  ventricle  (HV)  interval  at  baseline
nd  under  stress  during  incremental  atrial  pacing,  although
f  the  baseline  assessment  was  inconclusive,  the  EPS  was
ontinued  with  pharmacological  provocation  using  a  slow
nfusion  of  ajmaline  (1  mg/kg  intravenously).  Furthermore,
he  EPS  involved  the  assessment  of  the  inducibility  of  ven-
ricular  arrhythmia  by  programmed  ventricular  stimulation
nd  supraventricular  arrhythmia  by  any  atrial  stimulation
rotocol.
xclusion criteria
n  line  with  the  published  literature,  the  EPS  was  consid-
red  diagnostic  and  resulted  in  patients  being  excluded
rom  the  study  if  one  of  the  following  criteria  was  met:
inus  bradycardia  and  abnormal  sinus  node  recovery  time;
aseline  HV  interval  greater  or  equal  to  70  ms,  second-
r  third-degree  His-Purkinje  block  shown  during  incre-
ental  atrial  pacing  or  high-degree  His-Purkinje  block
rovoked  by  intravenous  administration  of  ajmaline;  induc-
ion  of  sustained  monomorphic  ventricular  tachycardia;ith  hypotensive  or  spontaneous  symptoms;  carotid  sinus
ypersensitivity;  symptomatic  orthostatic  hypotension  diag-
osed  by  standing  blood  pressure  measurement;  subclavian
teal  syndrome.
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ILR group
Patients  randomly  assigned  to  the  prolonged  monitoring
strategy  were  implanted  with  the  Reveal  ILR  (Medtronic
model  9526  Reveal  Plus,  replaced  by  model  9528  Reveal  DX
after  2008  and,  more  recently,  by  model  XT  Reveal;  Min-
neapolis,  MN,  USA)  in  the  left  upper  chest  region  under
local  anaesthesia  following  intravenous  administration  of  1  g
of  cefazolin.  The  ILR  was  a  continuous  electrocardiogram
monitor  capable  of  providing  spontaneous  automatic  single-
lead  electrocardiogram  recordings  for  up  to  42  minutes.
If  patients  experienced  spontaneous  symptoms,  they  were
invited  to  press  the  button  in  order  to  ‘freeze’  the  prior
electrocardiogram  recording,  which  was  downloaded  using
a  standard  pacemaker  programmer  (Medtronic  9290C).  After
implantation,  the  patients,  along  with  their  family  members
or  friends,  were  instructed  in  how  to  use  the  activator.  The
recommended  programme  mode  involved  one  manual  event
and  13  automatic  events  for  42  minutes  of  storage.  The
resulting  memory  conﬁguration  meant  that  the  automated
backup  of  manual  activations  was  able  to  detect  bradycardia
or  pauses  in  addition  to  prespeciﬁed  extreme  rates  or  pauses
(typically  <  30  beats/min,  >  160  beats/min  and  pauses  >  3  s).
Patients  were  told  to  activate  the  device  after  each  syncope
episode.  In  the  absence  of  recurrent  symptoms,  the  device
detected  any  asymptomatic  heart  rate  changes  that  were
likely  to  provide  clinical  insights  into  the  potential  causes
of  the  syncope  [21,22].  After  ILR  implantation,  patients  had
follow-up  visits  every  3  months  until  the  ﬁrst  symptomatic  or
asymptomatic  episode  documented  by  electrocardiogram  or
until  36  months.  The  mechanism  of  syncope  was  designated
by  the  endpoints  as  deﬁned  by  the  committee  members,
who  analysed  the  full  set  of  all  episodes.  In  the  case  of
battery  depletion  prior  to  the  study  end,  a  second  ILR  was
implanted.
Conventional strategy group
Patients  randomly  assigned  to  conventional  follow-up  were
seen  in  the  outpatient  department  at  3,  6,  12,  15,  18,
21,  24,  27,  30  and  33  months  after  randomization  and  at
the  study  end  (36  months).  At  each  visit,  arrhythmic  or
cardiovascular  events  were  recorded  and  a  12-lead  elec-
trocardiogram  was  obtained,  with  follow-up  continued  in
order  to  record  any  additional  endpoints  other  than  the
initial  endpoint.  At  each  visit,  a  Holter  monitor  was  used
for  7  days,  with  analyses  performed  using  the  R.Test  Evo-
lution  (RTE)  event  recorder  (Novacor,  Rueil  Malmaison,
France)  and  two  electrodes  placed  on  the  patient’s  body
[23,24].  The  RTE  event  recorder  ensured  continuous  elec-
trocardiogram  analysis,  with  any  abnormal  events  being
automatically  stored  in  a  20-minute  solid-state  memory,
which  was  autonomous  for  up  to  7  days.  Additionally,  the
patient  was  able  to  trigger  the  Holter  manually  [23]. The
RTE  was  programmed  to  recognize  10  types  of  arrhyth-
mic  events  and  one  category  of  ischaemic  event  [23,24].
The  patients  were  instructed  to  report  any  clinical  abnor-
mality  that  occurred  during  the  recording,  by  providing  a
detailed  description  and  precise  frequency  of  clinical  symp-
toms.  All  recordings  were  analysed  by  two  independent
observers,  with  a  third  being  used  in  case  of  discrepan-
cies.
u
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m workup  149
ndpoints
linically  signiﬁcant  symptomatic  and  asymptomatic
rrhythmias  were  deﬁned  as  follows:  pause  more  than
 seconds;  third-degree  AV  block;  heart  rate  less  than
0  beats/min  for  more  than  10  seconds  while  awake;  more
han  10  beats  of  wide  complex  tachycardia  consistent
ith  ventricular  tachycardia;  and  more  than  30  beats  of
arrow  complex  tachycardia  more  than  165  beats/min.
orderline  asymptomatic  arrhythmias  were  deﬁned  as
ollows:  less  than  10  seconds  of  second-  or  third-degree
V  block  (Mobitz  II);  or  heart  rate  less  than  30  beats/min
or  less  than  10  seconds  while  asleep.  These  endpoints
ere  based  on  the  guidelines  from  the  European  Society
f  Cardiology,  the  American  College  of  Cardiology,  the
merican  Heart  Association  and  the  North  American  Society
f  Pacing  and  Electrophysiology  regarding  the  implanta-
ion  of  cardiac  pacemakers  and  antiarrhythmia  devices
25,26].  The  primary  study  endpoint  was  reached  when
 symptom-rhythm  correlation  was  obtained  by  manual
ctivation  of  the  device  after  spontaneous  symptoms  or
hen  a  prespeciﬁed  signiﬁcant  asymptomatic  arrhythmia
as  observed.  Patients  with  borderline  arrhythmias  con-
inued  to  be  monitored  without  intervention.  The  primary
ndpoint  was  the  time  to  the  occurrence  of  signiﬁcant
ymptomatic  or  asymptomatic  events  such  as  those  deﬁned
bove,  thus  requiring  the  implantation  of  a  pacing  or  antiar-
hythmic  device  based  on  the  aforementioned  guidelines
25,26].
tatistical analysis
aseline  patient  characteristics  were  compared  between
he  ILR  group  and  the  conventional  group  using  Fisher’s
xact  test  for  categorical  variables  and  the  two-sample
-test  for  continuous  variables,  as  appropriate.  Summary
alues  were  reported  as  proportions  and  means  ±  standard
eviations.  For  all  time-to-event  analyses,  rates  were  esti-
ated  using  the  Kaplan-Meier  method  and  compared  by
he  log-rank  test.  Cox  regression  was  used  to  calculate
he  hazard  ratio  and  95%  conﬁdence  interval  of  risk  of
vents  in  a ﬁrst  model  and  risk  of  AV  block  III  in  a
econd  model  between  the  ILR  group  and  conventional
roup.  Crude  and  adjusted  hazard  ratios  were  presented.
atient  data  were  censored  at  the  time  of  last  follow-up,
ithdrawal  from  the  study  or  non-rhythmic  death.  Symp-
omatic  and  asymptomatic  events  episodes  were  recorded,
ith  a  safety  monitoring  board  reviewing  the  record-
ngs.  All  reported  levels  of  signiﬁcance  were  two-sided.
 probability  value  of  P  <  0.05  was  considered  statisti-
ally  signiﬁcant.  It  was  estimated  that  80  patients  would
eed  to  be  enrolled  to  detect  a 20%  event-difference  at
 years  in  favour  of  the  ILR  group,  with  80%  power,  a  two-
ided  0.05    level  and  a  two-sided  0.20    level,  assuming
hat  5%  of  patients  would  be  lost  to  follow-up  in  this
lderly  population.  Statistical  procedures  were  performed
sing  SPSS  for  Windows  (version  15.0)  and  Statview.  All
uthors  had  full  access  to  the  data,  take  responsibility
or  its  integrity  and  have  read  and  approved  the  ﬁnal
anuscript.
1 A.  Da  Costa  et  al.
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Table  2  Comparison  between  the  ILR  and  conventional
groups.
Characteristics  Group  1
(n  =  41)
Group  2
(n  = 37)
P
Age  (years)  76  ±  8  74  ±  8  0.6
Women  15  (36.6)  15  (40.5)  0.7
Structural  heart
disease
10 (24.5)  8  (22)  0.9
Arterial  pressure
(mmHg)
140 ±  15 140  ±  20 0.6
Prodromes  7  (17.1)  8  (21.6)  0.8
Prior  atrial
ﬁbrillation
7 (17.5)  5  (13.5)  0.9
Standard  electro-
cardiogram
Left  BBB  18  (43.9)  14  (37.8)  0.8
Right  BBB  6  (14.6)  5  (13.5)
Bifascicular
block
17  (41.5)  18  (48.6)
LVEF  (%)  56.5  ±  11  57  ±  11  0.9
Mean  AH
interval  (ms)
127  ±  65  108  ±  35  0.2
Sinus  recovery
time  (%)
124  ±  21  118  ±  12  0.2
Mean  HV
interval  (ms)
54.5  ±  6  55  ±  6  0.8
Maximal  HV
after  ajmaline
(ms)
72 ±  6  77  ±  4  0.8
Tilt  testing,
positive
14 (34.2)  11  (29.7)  0.950  
esults
tudy population
atient  characteristics  are  summarized  in  Table  1.  From  Jan-
ary  2005  to  December  2010,  78  patients  were  included
n  the  study.  Population  characteristics  were  as  follows:
ean  age  76  ±  8  years;  30  women  (38.5%);  18  presented  car-
iomyopathy  (23%);  and  12  had  a  history  of  atrial  ﬁbrillation
15.4%).  Among  the  18  cardiomyopathy  patients  included  in
ur  study,  12  had  documented  ischaemic  cardiomyopathy,
hile  six  had  left  ventricular  dysfunction  without  coronary
isease.  The  mean  LVEF  of  the  patients  presenting  car-
iomyopathy  was  48  ±  11%  versus  56.5  ±  11%  in  the  overall
opulation.  The  mean  HV  interval  was  55  ±  6  ms,  while  elec-
rocardiogram  abnormalities  were  as  follows:  34  left  BBBs;
1  right  BBBs;  and  33  bifascicular  blocks.  Subsequently,  41
atients  were  randomly  assigned  to  the  ILR  group  and  37
o  conventional  follow-up.  There  were  no  clinical,  electro-
ardiographic  or  echocardiographic  differences  between  the
wo  groups  (Table  2).
ollow-up
n  the  overall  population,  21  patients  (27%)  experienced
igniﬁcant  symptomatic  arrhythmic  events:  ventricular
achycardia  (n  =  1;  1.3%);  sudden  death  (n  =  2;  2.6%);  third-
egree  AV  block  (n  =  14;  18%);  and  sick  sinus  syndrome
n  =  4;  5.1%).  Events  were  detectable  in  19  patients,  with
 statistically  signiﬁcant  difference  found  between  the
LR  and  conventional  follow-up  groups  (n  =  15/41,  36.6%  vs
 =  4/37,  10.8%;  P  =  0.01)  (Table  2;  Fig.  1).  ILR-documented
vents  occurred  in  15  out  of  41  patients  after  a  median  of months  (interquartile  range,  1  to  23  months):  11  (26.8%)
atients  presented  third-degree  AV  block;  three  (7.3%)
resented  sick  sinus  syndrome  (sinus  arrest);  and  one
Table  1  Baseline  population  characteristics  (n  =  78).
Characteristics
Age  (years)  76  ±  8
Women  30  (38.5)
Structural  heart  disease  18  (23)
Hypertension  54  (69.2)
Diabetes  mellitus  16  (20.5)
Cholesterol  31  (39.7)
Tobacco  21  (27)
Prior  atrial  ﬁbrillation  12  (15.4)
Standard  electrocardiogram
Left  BBB  34  (43.5)
Right  BBB 11  (14.1)
Bifascicular  block  33  (42.3)
LVEF  (%) 56.5  ±  11
Mean  HV  interval  (ms) 55  ±  6
Maximal  HV  after  ajmaline  (ms) 74  ±  5
Tilt  testing,  positive  response 25  (32)
Data are mean ± standard deviation or number (%). BBB: bundle
branch block; LVEF: left ventricular ejection fraction; HV: His
to ventricular.
response
Events 15  (36.6) 4  (10.8)  0.01
AV  block  III 11  (26.8)  3  (8.1)
Sick  sinus
syndrome
3 (7.3) 1  (2.7)
Ventricular
tachycardia
1  (2.4) 0  (0)
Data are mean ± standard deviation or number (%). AV: atrio-
ventricular; BBB: bundle branch block; HV: His to ventricular;
ILR: implantable loop recorder; LVEF: left ventricular ejection
fraction.
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c2.4%)  presented  ventricular  tachycardia.  In  the  conven-
ional  group,  three  (8.1%)  patients  presented  third-degree
V  block  and  one  (2.7%)  presented  sick  sinus  syndrome,  after
 median  of  9  months  (interquartile  range,  3  to  12  months)
Fig.  1).
In  line  with  the  ﬁnal  diagnosis,  18  patients  were
mplanted  with  a  pacemaker,  while  one  received  an
mplantable  deﬁbrillator.  During  follow-up,  there  were  no
igniﬁcant  differences  observed  between  ILR  and  conven-
ional  groups  with  regard  to  the  number  of  presyncopes  and
yncopes  (0.7  ±  0.7  vs  0.5  ±  0.9;  P  =  0.3).  No  variables  were
dentiﬁed  to  predict  the  occurrence  of  AV  block,  including
BB  (hazard  ratios,  Table  3).  The  Kaplan-Meier  curve  showed
hat  patients  in  the  ILR  group  had  lower  survival  rates  con-
erning  AV  block  III  (P  =  0.01)  (Fig.  2).
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Figure 1. Kaplan-Meier estimates of the percentage of patients
remaining free of arrhythmia recurrence in the implantable loop
recorder (ILR) (green line) and conventional (blue line) groups. The
Kaplan-Meier curve shows that patients in the ILR group have lower
Figure 2. Kaplan-Meier estimates of the percentage of patients
remaining free of atrioventricular (AV) block III in the implantable
loop recorder (ILR) (green line) and conventional (blue line) groups.
The Kaplan-Meier curve shows that patients in the ILR group
h
P
P
n
S
a
H
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d
a
aevent-free survival rates; the log-rank test gave P = 0.01.
Discussion
Major ﬁndings
This  randomized,  prospective  study  demonstrated  and  con-
ﬁrmed  that  the  ILR  strategy  was  largely  superior  to  the
conventional  strategy  in  detecting  recurrent  signiﬁcant
events  in  patients  with  isolated  syncope,  BBB  and  negative
EPS;  accordingly,  this  approach  was  shown  to  be  a  favourable
early  therapeutic  strategy.  In  addition,  the  study  showed
that  the  true  prevalence  of  arrhythmic  events  detected
using  ILR  was  36.6%  at  2.5  years  (14.6%  incidence/year)  in
the  same  patient  population.
d
h
f
Table  3  Hazard  ratios  for  the  ILR  group  compared  with  the  c
IIIb.
Crude  hazard  ratio  (95%  CI)  
Prior  atrial  ﬁbrillation  0.7  (0.2—3.6)  
Standard  electrocardiogram
Left  BBB 1
Right  BBB 0.6  (0.08—5.4)  
Bifascicular  block 0.9  (0.3—2.6)  
Eventsa 3.4  (1.2—9.5)  
AV  block  IIIb 4.4  (1.2—15.8)  
AV: atrioventricular; BBB: bundle branch block; CI: conﬁdence interval
a First Cox model for risk factors for total events.
b Second Cox model for risk factors for AV block III.
c Hazard ratio adjusted for prior atrial ﬁbrillation and standard electroave lower AV block III-free survival rates; the log-rank test gave
 = 0.012.
rognosis of patients with syncope, BBB and
egative EPS results
yncope  is  a  frequent  reason  for  emergency  consultations,
ccounting  for  more  than  1.3%  of  all  adult  admissions  [1,27].
owever,  the  percentage  of  patients  leaving  hospital  with
 deﬁnite  diagnosis  is  variable,  ranging  from  52.5  to  87%
epending  on  the  study  [25,27—29].  Furthermore,  Soteri-
des  et  al.  showed  that  subjects  with  syncope  of  unknown
etiology  formed  a mixed  group  of  patients  at  high  risk  for
eath  [1].  However,  to  our  knowledge,  no  study  to  date
as  investigated  syncopal  patients  with  negative  workup
ollowing  the  ﬁrst  syncope  episode  [9—12,19,20,22]. For
onventional  group  for  risk  of  eventsa and  risk  of  AV  block
P  Adjusted  hazard  ratioc (95%  CI)  P
0.8  1.0  (0.3—3.7)  0.9
1 0.9
0.7  1.1  (0.2—5.4)  0.9
0.8  0.9  (0.3—2.3)  0.9
0.02  3.4  (1.2—9.6)  0.02
0.02  4.3  (1.2—15.7)  0.03
; ILR: implantable loop recorder.
cardiogram.
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atients  with  BBB  and  negative  EPS,  the  risk  of  recurrent
yncope  was  estimated  to  be  20%  at  2.5  years  and  40%
t  3  years,  according  to  the  studies  by  Click  et  al.  and
ink  et  al.,  respectively  [18,30].  In  general,  the  patients
nvestigated  in  these  studies  presented  more  than  one
ingle  syncope  episode  and,  in  most  cases,  syncope  was
uspected  to  be  due  to  paroxysmal  AV  block.  Given  this
ontext,  the  risk  of  developing  a  permanent  AV  block  was
stimated  to  be  5%/year  and  18%  after  2.5  years,  which
uggested  that  some  EPS  results  were,  in  fact,  false  neg-
tives  [17,18,30]. In  a  prospective  study,  McAnulty  et  al.
stablished  that  patients  with  symptomatic  BBB,  with  or
ithout  associated  cardiomyopathy,  had  an  estimated  17%
isk  of  developing  AV  block  versus  2%  for  asymptomatic
atients  [31]. In  the  2009  European  Society  of  Cardiol-
gy  guidelines  [19], patients  with  LBB  are  considered  at
igh  risk  and  syncope  in  this  patient  group  should  lead
o  ILR  (class  I,  level  B)  but  no  differentiation  was  made
etween  patients  with  one  or  more  syncope  episodes  and
o  prospective  comparison  strategy  has  been  done  to  date
19]. The  recommendation  for  patients  with  syncope  and
BB  could  also  lead  to  pacemaker  implantation  but  the
evel  of  proof  is  considered  as  class  IIa,  level  C  [19]. Lastly,
 recent  paper  underlined  the  role  of  ILR  in  a  subset  of
atients  despite  negative  EPS  but  the  patients  could  have
ad  more  than  one  syncope  episode  and  the  study  was  not
 comparative  strategy  [20]. In  our  study  involving  a  pop-
lation  with  isolated  syncope,  BBB  and  negative  workup
ncluding  EPS,  the  risk  of  arrhythmic  events  was  found  to
e  36.6%  at  2.5  years  (14.6%  incidence/year),  with  75%  of
rrhythmic  events  being  third-degree  AV  block  III  (10.7%  inci-
ence/year).  No  variables  were  identiﬁed  to  predict  the  risk
f  AV  block,  including  the  BBB  type  (left  versus  others;  not
igniﬁcant).
revious ILR studies in syncopal patients
hile  previous  studies  largely  validated  the  utility  of  ILR
n  patients  with  unexplained  syncope,  patients  experienc-
ng  a  ﬁrst  syncope  episode  along  with  BBB  and  negative
PS  were  not  included  in  the  majority  of  published
eports  [9—12,16,19,20,22]. Initially,  ILR  was  used  to  diag-
ose  patients  with  unexplained  syncope  in  the  case  of  a
ompleted  negative  workup.  In  a  small  series  of  highly
elected  patients,  symptom-electrocardiogram  correlation
as  achieved  in  88%  of  patients  within  a  mean  time  of
 months  following  implantation  [9,10,12].  In  the  guide-
ines  for  the  diagnosis  and  management  of  syncope,  pooled
ata  from  nine  studies  involving  506  patients  with  unex-
lained  syncope  showed  that  after  a  complete  conventional
nvestigation,  a  correlation  between  syncope  and  electro-
ardiogram  was  found  in  176  patients  (35%).  Among  these
atients,  56%  exhibited  a  systole  (or  bradycardia  in  a  few
ases)  at  the  time  of  the  recorded  event  and  11%  exhibited
achycardia,  while  33%  of  patients  had  no  arrhythmia  [26].
he  ISSUE  study  demonstrated  that  the  risk  of  developing
aroxysmal  AV  block  was  not  negligible,  with  the  incidence
stimated  to  be  about  35%  at  15  months  [2,3,6,16].  This
ast  study  involved  patients  with  recurrent  syncope  (median
umber,  3)  in  the  presence  of  BBB,  although  no  comparison
as  made  with  standard  conventional  testing  at  diagnosis
16].  In  our  study,  the  prevalence  of  AV  block  was  close  to
s
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7%  at  2.5  years  (10.7%/year)  in  the  ILR  group  compared  with
.13%  (3.3%/year)  in  the  conventional  group.  The  incidence
as  almost  three  times  lower  than  the  data  reported  by
rignole  et  al.  (28%/year)  [16]. The  main  explanation  for
his  discrepancy  is  that  patients  from  the  study  of  Brignole
t  al.  presented  more  than  one  syncopal  episode,  suggest-
ng  a  more  advanced  disease  [16]. Overall,  42%  of  patients
n  this  study  displayed  a  bifascicular  block,  with  right  BBB
eing  associated  with  right  axis  deviation,  meaning  that
atients  were  exposed  to  a  higher  risk  of  AV  block  [16].
ur  results  are  in  agreement  with  those  obtained  in  a  ret-
ospective  study  by  Pierre  et  al.  These  authors  found  that
n  patients  with  syncope  and  BBB,  the  risk  of  developing
V  block  was  13.8%  [32]. There  are  only  a  few  randomized
ublished  studies  on  ILR.  The  paper  by  Krahn  et  al.  is  the
ole  prospective  randomized  study  published  to  date  that
eports  on  the  utility  of  ILR  as  an  initial  approach,  while
emonstrating  its  superiority  over  conventional  testing  [11].
n this  study,  a  diagnosis  was  established  in  52%  of  ILR  group
atients  versus  20%  of  conventional  group  patients.  The
onventional  investigation  strategy  included  a  monitoring
eriod  of  2—4  weeks  using  an  external  loop  recorder,  fol-
owed  by  tilt-table  testing  and  EPS  [11]. Compared  with  our
tudy,  the  main  differences  with  the  study  by  Krahn  et  al.
ere  the  absence  of  an  EPS  investigation  in  the  ILR  group
nd  the  type  of  patients  included,  as  only  25%  of  patients
resented  had  BBB  [11]. Recently,  Moya  et  al.  reported
he  value  of  ILR  implantation  in  patients  with  syncope  and
BB  and  a  negative  EPS  [20]. In  their  study,  patients  exhib-
ted  one  or  more  syncope  episodes  and  80%  had  arrhythmia
vents,  demonstrating  that  their  population  was  quite  dif-
erent  from  our  study  that  included  only  patients  with  one
yncope  episode.  Accordingly,  our  study  results  support  ILR
mplantation  at  an  earlier  stage,  even  after  the  ﬁrst  syncope
pisode,  in  order  to  detect  signiﬁcant  arrhythmic  events.  To
ate,  prophylactic  pacemaker  implantation  has  been  clas-
iﬁed  as  class  IIA,  level  B  in  the  current  recommendations
or  patients  with  syncope  and  BBB  that  is  found  not  to  be
aused  by  AV  block  after  other  likely  causes,  speciﬁcally
entricular  tachycardia,  have  been  excluded  [19]. By  con-
rast,  ILR  implantation  in  patients  with  recurrent  syncope
s  categorized  as  class  I,  level  B,  while  unexplained  iso-
ated  syncope  is  categorized  as  class  II,  level  B  but  without
ifferentiation  between  patients  with  one  or  more  syn-
ope  episode  [19]. Our  study  ﬁndings  highlight  the  clinical
mpact  of  early  diagnosis  even  in  patients  with  one  syncope
pisode.
tudy implications
ur  randomized  prospective  study  is  the  ﬁrst  to  compare
n  ILR  strategy  with  conventional  follow-up  in  patients
resenting  a  ﬁrst  syncope  episode  along  with  BBB  and  neg-
tive  EPS  results.  Our  study  results  stress  the  superiority
f  the  ILR  strategy  over  conventional  follow-up,  with  the
ormer  approach  being  four  times  more  likely  to  detect  sig-
iﬁcant  arrhythmias,  especially  AV  block,  even  after  the
rst  syncope  episode.  Early  diagnosis  in  this  patient  sub-
et  allows  for  early  pacemaker  implantation—although  this
trategy  remains  to  be  validated  [33]—thereby  preventing
nnecessary  hospitalizations  or  syncope  recurrence,  which
an  be  particularly  harmful  for  elderly  patients.  Our  study
ative
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[Implantable  loop  recorder  in  isolated  syncope,  BBB  and  neg
ﬁndings  conﬁrm  that  AV  block  was  the  main  mechanism
for  syncope  recurrence  in  patients  exhibiting  BBB  and  one
syncope  episode,  being  responsible  for  75%  of  events  in
this  speciﬁc  patient  population,  with  a  10%  annual  inci-
dence.
Study limitations
While  the  type  of  strategy  may  have  an  impact  on  prognosis,
it  also  depends  on  the  patients  enrolled.  Our  patients  were
selected  on  the  basis  of  one  single  syncope  episode,  neg-
ative  EPS  and  BBB.  Accordingly,  the  percentage  of  events
in  our  population  is  quite  different  compared  with  the
high  percentage  of  arrhythmia  events  reported  by  Moya
et  al.  in  a  selected  population  with  more  than  one  syn-
cope  episode  (80%  of  events)  [20]. It  should,  however,  be
noted  that  ILR  is  not  necessary  in  patients  with  a  low
recurrence  risk  and  benign  syncope  [34]. In  addition,  the
sample  size  of  our  population  was  small  and,  ideally,  a
larger  number  of  patients  presenting  LBBB,  RBBB  or  bifas-
cicular  block  would  be  necessary  for  each  patient  group.
Furthermore,  a  longer  follow-up  duration  (e.g.  a  minimum  of
3—5  years/patient)  would  have  allowed  us  to  determine  the
cumulative  incidence  of  heart  block.  The  cost  implications
of  the  different  testing  strategies  were  not  evaluated  in  our
study.  Thus,  in  order  to  establish  the  cost-effectiveness  of
ILR  over  conventional  strategies,  further  studies  are  still
warranted.  Our  study  did  not  prove  that  early  pacemaker
implantation  is  superior  to  a  monitoring  strategy;  a  study
was  recently  initiated  to  evaluate  both  strategies  (SPRITELY
study)  [34].
Conclusions
This  randomized  prospective  study  demonstrated  that  in
patients  with  isolated  syncope,  BBB  and  negative  EPS
results,  an  ILR  strategy  proved  largely  superior  to  con-
ventional  clinical  follow-up  in  detecting  recurrent  events,
with  a  potential  impact  on  therapeutic  management.  In
this  patient  subset,  the  prevalence  of  arrhythmic  events
that  were  detected  using  ILR  was  36.6%  at  2.5  years  (14.6%
incidence/year)  versus  10.8%  (4.3%  incidence/year)  for
conventional  follow-up.  This  observation  highlights  the  use-
fulness  of  early  monitoring  in  patients  with  BBB  and  negative
EPS  even  after  the  ﬁrst  syncope  episode,  although  an  empiric
pacemaker  strategy  remains  to  be  validated  in  this  selected
population.
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